Biogen Inc.’s studies of its drug for a rare form of amyotrophic lateral sclerosis suggest the drug has a “treatment effect,” the Food and Drug Administration’s staff said in documents released ahead of a meeting out of outside advisers this week.
A money manager who caters to wealthy investors has gone out of his way to shield them from the long-standing risks he says have made the banking sector incompatible with the concept of sustainable investing.
Northern Ireland’s Democratic Unionist Party said its lawmakers will unanimously vote against Rishi Sunak’s post-Brexit deal for the region, in a significant blow to the UK prime minister.
Economist Joseph Stiglitz called Brazil’s interest rate levels “astounding,” aligning himself with a chorus of critics led by President Luiz Inacio Lula da Silva who believe the country’s borrowing costs are hindering economic growth.
Foot Locker Inc.’s new chief executive officer has unveiled a turnaround plan for the shoe retailer that hopes to break $9.5 billion in annual sales by 2026.
Group of Seven nations are unlikely to revise a price cap on Russian oil this week, despite initial evidence that crude is selling well below the current $60 threshold.
Amazon.com Inc. is laying off an additional 9,000 employees, adding to cuts that were already the largest round of firings in the company’s history.
A private equity dealmaker in New York may go down as one of the last bankers UBS Group AG ever poaches from its cross-town rival.
Profits from making one of the world’s dirtiest fuels are soaring in Asia as Chinese refiners snap up replacement feedstocks for dwindling Venezuelan oil shipments after a partial sanctions reprieve allowed exports to the US to resume.
As the demise of Credit Suisse Group AG reverberated from Sydney to New York City on Monday, workers were given a clear message: get back to work.
